Performance analysis of Agios Pharmaceuticals (AGIO)
Annual Return
Over the past 3 years, AGIO has had an average annual return of +2.05%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, AGIO has had an average annual return of -13.65%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, AGIO has had an average annual return of -6.94%, underperforming the benchmark SPY, which returned +15.44% annual.
Since Jul 24, 2013, AGIO has had an average annual return of -0.95%, underperforming the benchmark SPY, which returned +14.28% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1.69% | -17.16% | +47.54% | -20.69% | -14.57% | -24.14% | -9.26% | +3.55% | -19.35% | +37% | -35.72% | -42.06% |
| 2014 | 2013 | ||||||||||
| +367.78% | -23.43% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.80% | +10.17% | +11.91% | -17.24% | +5.01% | -5.85% | +1.69% | ||||||
| 2025 | +4.65% | +3.35% | -17.56% | +1.33% | +8.08% | +3.65% | +11.91% | +1.32% | +6.44% | +7.73% | -32.47% | -6.78% | -17.16% |
| 2024 | +1.56% | +42.88% | -9.52% | +11.15% | +11.82% | +18.65% | +7.61% | -1.06% | -3.22% | -0% | +33.67% | -44.67% | +47.54% |
| 2023 | +4.99% | -14.15% | -9.24% | -0.44% | +10.55% | +12.03% | -6.36% | +3.43% | -9.77% | -15.10% | +5.81% | +0.18% | -20.69% |
| 2022 | -6.02% | +0.78% | -6.49% | -24.52% | -11.39% | +13.88% | -2.71% | +18.21% | +10.91% | -2.62% | +9.45% | -6.84% | -14.57% |
| 2021 | +8.40% | +1% | +8.86% | +8.06% | -0.04% | -1.20% | -12.74% | -7.09% | +3.29% | +1.84% | -24.22% | -7.72% | -24.14% |
| 2020 | +2.06% | -2.57% | -25.27% | +15.95% | +25.77% | +3.36% | -15.26% | -9.50% | -14.66% | +14.49% | +15.60% | -6.46% | -9.26% |
| 2019 | +16.25% | +21.02% | +3.96% | -17.08% | -17.44% | +8.04% | -3.55% | -21.12% | -14.62% | -7.16% | +29.33% | +22.75% | +3.55% |
| 2018 | +37.76% | +2.07% | +1.73% | +2.60% | +11.43% | -9.91% | +2.59% | -6.58% | -4.46% | -18.23% | +4.35% | -29.92% | -19.35% |
| 2017 | +3.11% | +12.58% | +20.56% | -14.88% | -6.12% | +10.24% | +8.73% | +13.08% | +5.52% | -3.72% | -4.23% | -7.11% | +37% |
Drawdown analysis of Agios Pharmaceuticals (AGIO)
The maximum drawdown for the AGIO was -87.36%, occurring on Jun 14, 2022. This drawdown has not yet recovered.
The current AGIO drawdown is -79.50%.
Since Jul 24, 2013 AGIO has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 6 times
- 20% or more: 7 times
- 10% or more: 11 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -87.36% | Jan 14, 2015 | 1867 | Jun 14, 2022 | Ongoing | Ongoing | Ongoing |
| -51.60% | Oct 4, 2013 | 36 | Nov 25, 2013 | 33 | Jan 14, 2014 | 69 |
| -38.02% | Jan 15, 2014 | 12 | Feb 3, 2014 | 23 | Mar 7, 2014 | 35 |
| -34.21% | Apr 9, 2014 | 28 | May 20, 2014 | 22 | Jun 20, 2014 | 50 |
| -32.91% | Jun 20, 2014 | 18 | Jul 17, 2014 | 48 | Sep 24, 2014 | 66 |
| -30.88% | Aug 14, 2013 | 9 | Aug 27, 2013 | 27 | Oct 4, 2013 | 36 |
| -24.78% | Mar 10, 2014 | 18 | Apr 3, 2014 | 3 | Apr 8, 2014 | 21 |
| -14.59% | Oct 30, 2014 | 6 | Nov 7, 2014 | 3 | Nov 12, 2014 | 9 |
| -11.23% | Dec 22, 2014 | 1 | Dec 23, 2014 | 10 | Jan 8, 2015 | 11 |
| -11.19% | Jul 24, 2013 | 1 | Jul 25, 2013 | 13 | Aug 13, 2013 | 14 |
| -10.11% | Dec 12, 2014 | 2 | Dec 16, 2014 | 2 | Dec 18, 2014 | 4 |
| -8.45% | Sep 29, 2014 | 9 | Oct 10, 2014 | 6 | Oct 20, 2014 | 15 |
| -6.02% | Nov 26, 2014 | 2 | Dec 1, 2014 | 3 | Dec 4, 2014 | 5 |
| -3.53% | Nov 12, 2014 | 4 | Nov 18, 2014 | 1 | Nov 19, 2014 | 5 |
| -3.08% | Nov 19, 2014 | 1 | Nov 20, 2014 | 2 | Nov 24, 2014 | 3 |
| -1.55% | Oct 24, 2014 | 3 | Oct 29, 2014 | 1 | Oct 30, 2014 | 4 |
| -1.23% | Jan 12, 2015 | 1 | Jan 13, 2015 | 1 | Jan 14, 2015 | 2 |
| -0.08% | Dec 18, 2014 | 1 | Dec 19, 2014 | 1 | Dec 22, 2014 | 2 |